Congress Park Capital LLC Gilead Sciences, Inc. Transaction History

Congress Park Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $188,240 - $235,885	-3,250 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $195,000 - $222,494	3,250 New	3,250 $210,000
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $219,205 - $280,770	-3,500 Closed	0 $0
Q1 2019 Apr 18, 2019	SELL	$62.53 - $70.05 $12,506 - $14,010	-200 Reduced 5.41%	3,500 $228,000
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $136,575 - $166,500	-1,875 Reduced 33.63%	3,700 $279,000
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $396,661 - $465,624	5,575	5,575 $399,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Congress Park Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Congress Park Capital LLC with notifications on news.